Uridine

Uridine is a pyrimidine nucleoside that serves as a precursor to RNA synthesis and plays a central role in phosphatidylcholine biosynthesis via the Kennedy pathway. It supports neuronal membrane formation, synaptic plasticity, and dopaminergic signaling by increasing dendritic spine density and modulating P2 purinergic receptors.

Origin & History

Uridine is a naturally occurring nucleoside composed of uracil attached to a ribose sugar, found in all living organisms as a component of RNA. It is sourced from dietary intake including yeast, organ meats, sugarcane, tomatoes, and broccoli, and is typically available as synthetic oral supplements or derived from microbial fermentation for pharmaceutical use.

Historical & Cultural Context

No historical traditional medicine use was identified in the research sources. Uridine research is entirely modern, focused on biomedical supplementation rather than ethnobotanical or ancient medicine systems.

Health Benefits

• May reduce depression symptoms in adolescents with bipolar disorder - open-label study (n=7) showed CDRS-R score reduction from 65.6 to 27.2 after 6 weeks (preliminary evidence)
• Effective for neuralgic pain when combined with cytidine and vitamin B12 - RCT (PMID: 28243144) found combination as effective as diclofenac (moderate evidence)
• Reduces low back pain in combination therapy - RCT (PMID: 33116795) showed nucleotide combination superior to B vitamins + diclofenac (moderate evidence)
• Protects against mitochondrial neurotoxicity from nucleoside analogues - animal studies (PMID: 20032772) demonstrate neuroprotective effects (preliminary evidence)
• Supports synaptic membrane formation and neuronal repair through phospholipid synthesis pathways (mechanistic evidence)

How It Works

Uridine crosses the blood-brain barrier and is phosphorylated to UTP, which enters the Kennedy pathway to synthesize phosphatidylcholine, a key neuronal membrane phospholipid. It upregulates dopamine receptor density and enhances synaptic signaling by increasing dendritic spine formation, partly through activation of P2Y and P2X purinergic receptors. Additionally, uridine serves as a substrate for cytidine diphosphate-choline (CDP-choline) synthesis, directly supporting neuronal membrane integrity and repair.

Scientific Research

Clinical evidence includes an ongoing RCT (NCT01805440) testing 500mg twice daily in adolescents with bipolar depression, and completed trials showing efficacy for neuralgic and low back pain when combined with cytidine and B12 (PMIDs: 28243144, 33116795). An open-label case series (n=7) demonstrated significant depression score improvements, though no meta-analyses have been conducted to date.

Clinical Summary

A small open-label study (n=7) in adolescents with bipolar depression showed uridine supplementation reduced Children's Depression Rating Scale-Revised (CDRS-R) scores from 65.6 to 27.2 over 6 weeks, though the lack of a control group limits conclusions. A randomized controlled trial (PMID: 28243144) demonstrated that a combination of uridine, cytidine, and vitamin B12 was effective in reducing neuralgic pain, providing stronger evidence for peripheral nerve applications. Preclinical rodent studies show uridine increases dendritic spine density and enhances cognitive performance when combined with choline and DHA, forming the basis of the Souvenaid formulation studied in Alzheimer's disease. Overall, evidence in humans remains preliminary to moderate depending on the indication, with larger placebo-controlled trials needed.

Nutritional Profile

Uridine is a pyrimidine nucleoside (molecular weight: 244.2 g/mol) composed of uracil linked to ribose. It is not a traditional macronutrient or micronutrient but a bioactive compound. Typical supplemental doses range from 500–1000 mg/day. Endogenous plasma concentrations in humans are approximately 3–8 µmol/L under fasting conditions. Dietary sources include beer (0.05–1.0 mg/mL), brewer's yeast, liver, fish, broccoli, and tomatoes, though concentrations are generally low. As a free nucleoside, oral bioavailability is estimated at roughly 5–10% due to extensive first-pass metabolism; hepatic phosphorylation and incorporation into RNA limit systemic availability. Triacetyluridine (TAU), a prodrug form, has significantly higher bioavailability (~6–7× compared to uridine). Uridine participates in the CDP-choline (Kennedy) pathway, contributing to phosphatidylcholine and membrane phospholipid synthesis. It serves as a precursor to UTP and CTP, nucleotides critical for glycosylation reactions and RNA synthesis. No established Dietary Reference Intake (DRI) exists. It contains negligible caloric value as typically supplemented. Synergistic effects observed with cytidine and vitamin B12 in neurological applications (as referenced in combination RCT evidence). No significant fat, protein, or carbohydrate content in pure compound form.

Preparation & Dosage

Clinically studied oral dosage: 500 mg twice daily (total 1 g/day) as powder or capsule for bipolar depression in adolescents (6 weeks duration). For neuralgic and low back pain, uridine is used in standardized combinations with cytidine and vitamin B12, though specific doses were not detailed in trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Cytidine, Vitamin B12, Choline, DHA, Gabapentin

Safety & Interactions

Uridine is generally well tolerated at supplemental doses of 500–1000 mg/day, with mild gastrointestinal side effects such as nausea or loose stools reported in some users. It may interact with anticonvulsants, particularly capecitabine and fluorouracil-based chemotherapy drugs, as uridine is a metabolic competitor with these fluoropyrimidine compounds and can reduce their efficacy. Individuals with hereditary orotic aciduria or certain urea cycle disorders should use uridine only under medical supervision. Safety data in pregnancy and lactation are insufficient, and use is not recommended in those populations without physician guidance.